HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eva Brand Selected Research

migalastat

1/2022Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
4/2021Fabry Disease: The Current Treatment Landscape.
3/2021Treatment of fabry disease with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
1/2021Precision medicine in Fabry disease.
12/2020In Vitro and In Vivo Amenability to Migalastat in Fabry Disease.
1/2020Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).
1/2019Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eva Brand Research Topics

Disease

31Fabry Disease (Fabry's Disease)
01/2022 - 01/2012
8Stroke (Strokes)
11/2021 - 04/2009
8Hypertension (High Blood Pressure)
03/2015 - 02/2004
7Cardiovascular Diseases (Cardiovascular Disease)
10/2017 - 08/2007
6Body Weight (Weight, Body)
11/2021 - 04/2003
4Disease Progression
11/2021 - 12/2018
4Cardiomyopathies (Cardiomyopathy)
11/2021 - 01/2020
4Cardiac Arrhythmias (Arrythmia)
11/2021 - 04/2009
4Lysosomal Storage Diseases (Lysosomal Storage Disease)
04/2021 - 01/2020
3Renal Insufficiency (Renal Failure)
11/2021 - 01/2021
3Essential Hypertension
03/2007 - 11/2002
2Peripheral Arterial Disease
10/2021 - 09/2017
2Coronary Disease (Coronary Heart Disease)
10/2021 - 08/2007
2Chronic Renal Insufficiency
01/2021 - 01/2020
2Heart Failure
10/2017 - 12/2014
2Diabetes Mellitus
09/2017 - 03/2010
2Atrial Fibrillation
04/2016 - 04/2009
1Dysbiosis
01/2022
1Heart Valve Diseases (Valvular Heart Disease)
10/2021
1Cardiomegaly (Heart Hypertrophy)
01/2020
1Hepatolenticular Degeneration (Wilson's Disease)
01/2020
1Liver Diseases (Liver Disease)
01/2020
1Leukocytosis (Pleocytosis)
01/2020
1Pathologic Constriction (Stenosis)
01/2019
1Albuminuria
01/2019
1Cystinosis
01/2018
1Neoplasms (Cancer)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Cerebral Infarction
10/2017
1Neuroblastoma
01/2017
1Fibrosis (Cirrhosis)
04/2016
1Transient Ischemic Attack
01/2016
1Vascular Diseases (Vascular Disease)
03/2015
1Mitral Valve Insufficiency (Mitral Regurgitation)
12/2014
1Small Fiber Neuropathy
11/2014
1Ischemic Stroke
11/2014
1Neurologic Manifestations (Neurological Manifestations)
11/2014
1Diarrhea
04/2014
1Chronic Pain
04/2014
1Pain (Aches)
04/2014
1Myocardial Infarction
04/2013
1Acute Kidney Injury (Acute Renal Failure)
01/2012
1Hypertensive Encephalopathy
11/2011
1Inflammation (Inflammations)
02/2011
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
09/2009

Drug/Important Bio-Agent (IBA)

15GalactosidasesIBA
01/2022 - 01/2012
9AntibodiesIBA
11/2021 - 11/2011
7globotriaosylceramide (globotriosylceramide)IBA
01/2022 - 12/2018
7migalastatIBA
01/2022 - 01/2019
7EnzymesIBA
01/2022 - 01/2020
7Pharmaceutical PreparationsIBA
11/2021 - 01/2018
4CreatinineIBA
10/2021 - 03/2010
4GlycosphingolipidsIBA
04/2021 - 01/2012
4agalsidase betaFDA Link
04/2021 - 04/2014
4agalsidase alfaIBA
04/2021 - 04/2014
4alpha-Galactosidase (Beano)IBA
10/2020 - 11/2014
4SodiumIBA
02/2006 - 02/2004
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2004 - 08/2002
4Cytochrome P-450 CYP11B2 (CYP11B2)IBA
12/2004 - 08/2002
3globotriaosyl lysosphingolipidIBA
01/2021 - 01/2016
3Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2002
3SaltsIBA
10/2017 - 08/2004
3AngiotensinogenIBA
10/2004 - 11/2002
2Insulin (Novolin)FDA Link
09/2017 - 04/2003
2adducinIBA
10/2005 - 08/2002
2Angiotensin IIIBA
12/2004 - 10/2004
1PrebioticsIBA
01/2022
1AlbuminsIBA
10/2021
1EpitopesIBA
09/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1CopperIBA
01/2020
1Oligoclonal BandsIBA
01/2020
1HydrolasesIBA
10/2019
1MicroRNAs (MicroRNA)IBA
10/2019
1Annexin A5IBA
01/2018
1Neutralizing AntibodiesIBA
01/2018
1Cystine (L-Cystine)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1MethyltransferasesIBA
01/2017
1Anti-Arrhythmia AgentsIBA
04/2016
1CalciumIBA
04/2016
1Ion Channels (Ion Channel)IBA
04/2016
1factor V LeidenIBA
03/2015
1Genetic Markers (Genetic Marker)IBA
12/2014
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2013
1Lipoproteins (Lipoprotein)IBA
04/2013
1BiglycanIBA
04/2013
1Proteoglycans (Proteoglycan)IBA
04/2013
1ApolipoproteinsIBA
04/2013
1Contrast MediaIBA
01/2012
1Type 1 Angiotensin ReceptorIBA
11/2011
1Acute-Phase Proteins (Acute-Phase Protein)IBA
02/2011
1C-Reactive ProteinIBA
02/2011
1OsteoprotegerinIBA
10/2009

Therapy/Procedure

15Enzyme Replacement Therapy
11/2021 - 01/2012
5Therapeutics
01/2022 - 01/2018
2Drug Tapering
03/2016 - 04/2014
1Precision Medicine
01/2021
1Cardiac Resynchronization Therapy
12/2014